Health
Pharmacy staff from Walgreens, CVS say they’re at a breaking point — here’s what their days look like
Signs offering COVID-19 vaccinations are seen outside of a CVS pharmacy in Washington, DC. Mandel Ngan | AFP | Getty Images Many pharmacy employees at some of the largest U.S. drugstore chains say they’re reaching a breaking point. On top of verifying, filling and dispensing prescriptions, pharmacists and support staff are responsible for administering vaccines, […]
Read More
Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data
CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study. That moves the pharmaceutical giant and its German partner BioNTech one step closer to […]
Read More
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down […]
Read More
Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth
Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio. The pharmaceutical giant also increased its full-year […]
Read More
RSV vaccine from GSK shows potential to protect adults 50 to 59
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, a disease that causes thousands of hospitalizations and deaths […]
Read More
Picking health insurance can be tricky: 6 key terms to know as open enrollment starts
Sdi Productions | E+ | Getty Images Many people will soon be picking their health insurance plans for 2024: November is a common month for workplace open enrollment, and the public marketplace opens Nov. 1. But choosing a health plan can be tricky. In fact, a 2017 study found many people lose money due to […]
Read More
We’re buying more of this life sciences stock after an earnings-driven decline
The stock is under pressure in early trading due to uncertainty around the recovery in a key business. Source
Read More
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Most analysts predict the market for new weight loss drugs like Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. On Monday, Citi raised its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That viewpoint seems […]
Read More
These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
One of the downsides of taking new anti-obesity medications is that patients tend to lose lean muscle mass along with body fat. What this means for patients over the long term isn’t fully known, but there are several pharmaceutical companies studying the side effect and hoping to develop therapies that might regulate the condition. In […]
Read More
Supreme Court blocks restrictions on Biden administration efforts to remove contentious social media posts
The US Supreme Court in Washington, DC, on June 27, 2023. Kevin Dietsch | Getty Images WASHINGTON — The Supreme Court on Friday blocked in full a lower court ruling that would have curbed the Biden administration’s ability to communicate with social media companies about contentious content on such issues as Covid-19. The decision in […]
Read More